Apigenin may exert its effects by interacting with various signaling pathways involved in cancer development, such as the PI3K/AKT/mTOR pathway, NF-κB, signal transducer and activator of transcription 3 (Stat3) pathways, angiogenesis, apoptosis, cell cycle, and inflammation. This evidence concerns the gene NFKB1 and cancer.